Remove 2026 Remove Prescription Remove Side effects
article thumbnail

Jazz Pharma uses flying pig for huge grey area DTC

World of DTC Marketing

billion by 2026. Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC.

Pharma 181
article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

A generic here will improve access in OAB to a product with less side effects, which is especially important in the elderly population, Casberg noted. This product would be a more potent prescription version than the OTCs, Casberg notes. Starting in 2026, the provision will affect 10 Part D drugs.

article thumbnail

FDA makes moves to advance ALS research ahead of upcoming Amylyx AdCom

Pharmaceutical Technology

The Act authorizes the appropriation of $100,000,000 per fiscal year from 2022 to 2026. Sanofi's Rilutek, which has generic versions available, has shown a 35% survival benefit in stage 4 ALS, but the drug has several side effects which affect the patient’s quality of life. The FDA’s action plan. The future of ALS research.

FDA 98